Correlating cellulose derivative intrinsic viscosity with mechanical susceptibility of swollen hydrophilic matrix tablets
- PMID: 22711256
- PMCID: PMC3429674
- DOI: 10.1208/s12249-012-9811-6
Correlating cellulose derivative intrinsic viscosity with mechanical susceptibility of swollen hydrophilic matrix tablets
Abstract
Hydrophilic matrix tablets are prone to mechanical stress while passing through the gastrointestinal tract, which may result in inappropriate drug-release characteristics. Intrinsic viscosity is a physical polymer property that can be directly compared across various types and grades of polymers and correlated with the mechanical susceptibility of swollen matrix tablets. Five tablet formulations containing different HPMC and HPC polymers were prepared and analyzed using an in vitro glass bead manipulation test. The dissolution rate results were modeled using the Korsmeyer-Peppas equation and a correlation was found between the fit constants k and n, goodness-of-fit measure parameters, and intrinsic viscosity. Moreover, the dissolution profiles were used to calculate the degree of mechanical susceptibility for each formulation, defined as the ratio of the average dissolution rate after manipulation and the initial dissolution rate before manipulation. It was confirmed that an increased intrinsic viscosity polymer value resulted in a decrease in mechanical susceptibility. Considering this, two simple rules were defined for designing robust matrix tablets with respect to mechanical stresses.
Figures







Similar articles
-
Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.AAPS PharmSciTech. 2015 Apr;16(2):398-406. doi: 10.1208/s12249-014-0234-4. Epub 2014 Oct 18. AAPS PharmSciTech. 2015. PMID: 25331194 Free PMC article. Clinical Trial.
-
In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.Drug Dev Ind Pharm. 2013 Nov;39(11):1651-62. doi: 10.3109/03639045.2012.729146. Epub 2012 Oct 24. Drug Dev Ind Pharm. 2013. PMID: 23094867
-
Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.Curr Drug Deliv. 2022;19(5):520-533. doi: 10.2174/1567201818666210820101549. Curr Drug Deliv. 2022. PMID: 34420504
-
Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M.Drug Dev Ind Pharm. 2012 May;38(5):515-20. doi: 10.3109/03639045.2011.620966. Epub 2011 Oct 7. Drug Dev Ind Pharm. 2012. PMID: 21978389 Review.
-
[Modern polymers in matrix tablets technology].Polim Med. 2014 Jul-Sep;44(3):189-96. Polim Med. 2014. PMID: 25739125 Review. Polish.
Cited by
-
A Rational Approach to Predicting Immediate Release Formulation Behavior in Multiple Gastric Motility Patterns: A Combination of a Biorelevant Apparatus, Design of Experiments, and Machine Learning.Pharmaceutics. 2023 Jul 31;15(8):2056. doi: 10.3390/pharmaceutics15082056. Pharmaceutics. 2023. PMID: 37631270 Free PMC article.
-
Gel Strength of Hydrophilic Matrix Tablets in Terms of In Vitro Robustness.Pharm Res. 2021 Jul;38(7):1297-1306. doi: 10.1007/s11095-021-03068-y. Epub 2021 Jun 21. Pharm Res. 2021. PMID: 34152536 Free PMC article.
-
A novel beads-based dissolution method for the in vitro evaluation of extended release HPMC matrix tablets and the correlation with the in vivo data.AAPS J. 2013 Jan;15(1):267-77. doi: 10.1208/s12248-012-9422-x. Epub 2012 Nov 28. AAPS J. 2013. PMID: 23188526 Free PMC article. Clinical Trial.
-
Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation.NPJ Biofilms Microbiomes. 2021 Jul 9;7(1):58. doi: 10.1038/s41522-021-00228-1. NPJ Biofilms Microbiomes. 2021. PMID: 34244520 Free PMC article.
-
Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.AAPS PharmSciTech. 2015 Apr;16(2):398-406. doi: 10.1208/s12249-014-0234-4. Epub 2014 Oct 18. AAPS PharmSciTech. 2015. PMID: 25331194 Free PMC article. Clinical Trial.
References
-
- Liu P, Ju T, Qiu Y. Diffusion-controlled drug delivery systems. In: Li X, Jasti BR, editors. Design of controlled release drug delivery systems. United States: McGraw-Hill; 2006. pp. 107–137.
-
- Wang Z, Shmeis RA. Dissolution controlled drug delivery systems. In: Li X, Jasti BR, editors. Design of controlled release drug delivery systems. United States: McGraw-Hill; 2006. pp. 139–172.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources